Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Claritas Pharmaceuticals Inc
V.CLAS.H
Alternate Symbol(s):
CLAZF
Healthcare
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID...
viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:CLAS.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Aug 02, 2022 6:05pm
RE: Mr. Red~one
Oh don't worry little red , but since you asked....when pumpers show up you need to know that: "His PUMP may contain certain forward-looking information and statements ("
...more
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Aug 02, 2022 6:02pm
Mr. Red~one
What do you think sir shuld i do dsomething....gee whizz, oh my oh my
(27)
•••
PTBailey
X
View Profile
View Bullboard History
Comment by
PTBailey
on Aug 02, 2022 3:05pm
RE:Mr Bailey
Sure doesn't look good at this point, have to wait and see. I would just like to hear one way or the other.
(89)
•••
polo22
X
View Profile
View Bullboard History
Post by
polo22
on Aug 02, 2022 10:28am
Mr Bailey
This looks like a big scam!!!! what is your thinking?
(1)
•••
losingmyshirt
X
View Profile
View Bullboard History
Post by
losingmyshirt
on Jul 27, 2022 9:41am
Just reach out and ask Robert Farrell where the $ went
Interesting little webpage with Bob's number.. Happy Wednesday https://clustrmaps.com/person/Farrell-85n24l
(1033)
•••
Savage97
X
View Profile
View Bullboard History
Post by
Savage97
on Jul 26, 2022 11:06pm
Cannabis reform proposal to reach president’s desk
The main intent being to streamline the process for research $$$ https://www.marijuanamoment.net/house-debates-bipartisan-marijuana-research-bill-with-vote-expected-imminently-before-heading
...more
(16)
•••
Scotty
X
View Profile
View Bullboard History
Comment by
Scotty
on Jul 26, 2022 8:22pm
RE:CTO
Didn't you hear? KLY is broke, no paychecks ATM lmao.
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Jul 23, 2022 8:41pm
CTO
Where's a paid pumper when you need one?
(1)
•••
Red~One
X
View Profile
View Bullboard History
Comment by
Red~One
on Jul 23, 2022 7:59pm
RE:RE:"selliing a sub-license "
It is possible that without meeting any Milestones that Claritas/Robert Farewell is in danger of losing Licences for R107 from the Salzman Team, losing any further milestone/benchmark payments from
...more
(16)
•••
Scotty
X
View Profile
View Bullboard History
Comment by
Scotty
on Jul 23, 2022 6:57pm
RE:"selliing a sub-license "
Hey hey to be fair, kly has millions in debt and a licence for a phase 1 drug not being developed. Who wouldn't want to buy a red balance sheet?!?!?
(1)
•••
losingmyshirt
X
View Profile
View Bullboard History
Post by
losingmyshirt
on Jul 22, 2022 3:38pm
Just ask Bob why he did it?
Bob's number on Sedar 415 218-3900
(1)
•••
losingmyshirt
X
View Profile
View Bullboard History
Post by
losingmyshirt
on Jul 22, 2022 10:18am
"selliing a sub-license "
THEY HAVE NOTHING TO SUB LICENCE.
(86)
•••
GreatGabbo
X
View Profile
View Bullboard History
Post by
GreatGabbo
on Jul 22, 2022 10:08am
This junk is FINISHED. 🤮
Bob? More like ROB (shareholders) This junk is finished. GLTA!
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Jul 22, 2022 10:04am
Interesting
".... The Company’s lack of financial resources has also impacted the Company’s research and development activities. Specifically, the Company has not been able to pay fees due to the third
...more
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Jul 22, 2022 10:00am
News
Claritas Announces Issuance of Failure-to-file Cease Trade Order by BCSC SAN FRANCISCO, CA -- (July 21, 2022) – Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the "
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >